180 life sciences corp. regains full compliance with nasdaq continued listing rules

Palo alto, ca / accesswire / december 12, 2024 / 180 life sciences corp. ("180" or the "company") is pleased to announce that it has regained compliance with nasdaq listing rule 5605(c)(2), which requires nasdaq listed companies to maintain an audit committee consisting of three independent directors. this development follows the recent appointment of mr.
NDAQ Ratings Summary
NDAQ Quant Ranking